Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.

Jan Balzarini; Heidi Pelemans; María‐Jesús Pérez‐Pérez; Ana San‐Félix; Marı́a-José Camarasa; De Clercq Erik; Anna Karlsson

doi:10.1016/s0026-895x(25)09081-9

Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine. — Jan Balzarini (1996) | RDL Network

Back

Home
Publications
Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.

Shared by

De Clercq Erik

KU Leuven

Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.

Article 1996 en

Authors

JB
Jan Balzarini
HP
Heidi Pelemans
MP
María‐Jesús Pérez‐Pérez

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/s0026-895x(25)09081-9
Year: 1996
Published: —
Language: en

Article Details

Volume: 49
Issue: 5
Link Of The Paper: https://doi.org/10.1016/s0026-895x(25)09081-9

Timeline

Created:June 19, 2026

Related publications

Article2004

Susceptibility of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Type 1 Reverse Transcriptase Chimeras to Non-Nucleoside RT Inhibitors

Johan Auwerx, Robert Esnouf, De Clercq Erik, Jan Balzarini

Article1993

Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.

Zeger Debyser, K De Vreese, P P Knops-Gerrits, Veerle Baekelandt, Ramagauri Bhikhabhai, B. Strandberg, Rudi Pauwels, Jozef Anné, Jan Desmyter, De Clercq Erik

Article1991

Chemotherapy of the acquired immune deficiency syndrome (AIDS): Non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptase

De Clercq Erik

Article1999

Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV

Myriam Witvrouw, Christophe Pannecouque, Kristel Van Laethem, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article1996

What can be Expected from Non‐nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV‐1) Infections?

De Clercq Erik